A population-based cohort study of mortality among adults prescribed paracetamol in Denmark

Journal of Clinical Epidemiology

Volumn 56, Issue 8, 2003, Pages 796-801

  Lipworth, Loren ^a,b   Friis, Søren ^c   Mellemkjær, Lene ^c   Signorello, Lisa B ^a,b   Johnsen, Søren P ^d,e   Nielsen, Gunnar L ^e   McLaughlin, Joseph K ^a,b   Blot, William J ^a,b   Olsen, Jørgen H ^b,c  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Mortality; Paracetamol; Population based

Indexed keywords

PARACETAMOL;

ADULT; AGED; ARTICLE; CANCER; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DENMARK; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MALE; MORTALITY; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0042885914     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(03)00152-5     Document Type: Article

References (17)

1. Andrade S.E., Martinez C., Walker A.M. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol. 51:1998;1357-1365.
2. Day R.O., Graham G.G., Whelton A. The position of paracetamol in the world of analgesics. Am J Ther. 7:2000;51-54.
3. Prescott L.F. Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther. 7:2000;99-114.
4. McLaughlin J.K., Lipworth L., Chow W.H., et al. Analgesic use and chronic renal failure: a critical review of the epidemiologic literature. Kidney Int. 54:1998;679-686.
5. International Agency for Research on Cancer. Analgesic mixtures containing phenacetin. IARC Monographs on the evaluation of carcinogenic risks to humans (Suppl 7). Overall evaluations of carcinogenicity: an updating of IARC Monographs 1 to 42. 1987;IARC, Lyon.
6. International Agency for Research on Cancer. Paracetamol. IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 73. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. 1999;IARC, Lyon.
7. Nielsen G.L., Sørensen H.T., Zhou W., et al. The pharmacoepidemiologic prescription database of North Jutland: a valid tool in pharmacoepidemiological research. Int J Risk Safety Med. 10:1997;203-205.
8. Sørensen H.T., Larsen B.O. A population-based Danish data resource with possible high validity in pharmacoepidemiologic research. J Med Sys. 18:1994;33-38.
9. Capellá D. Descriptive tools and analysis. Dukes M.N.G. Drug utilization studies: methods and uses. 1993;55-78 WHO Regional Publications, Copenhagen.
10. Signorello L.B., McLaughlin J.K., Lipworth L., et al. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther. 9:2002;199-205.
11. Cramer D.W., Harlow B.L., Titus-Ernstoff L., et al. Over the counter analgesics and risk of ovarian cancer. Lancet. 351:1998;104-107.
12. Rodriguez C., Henley S.J., Calle E.E., et al. Paracetamol and risk of ovarian cancer mortality in a prospective study of women in the USA. [letter] Lancet. 352:1998;1354-1355.
13. Moysich K.B., Mettlin C., Piver M.S., et al. Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 10:2001;903-906.
14. Rosenberg L., Palmer J.R., Rao R.S., et al. A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 9:2000;933-937.
15. Fored M., Ejerblad E., Lindblad P., et al. Acetaminophen, aspirin and chronic renal failure: a nationwide case-control study in Sweden. N Engl J Med. 345:2001;1801-1808.
16. Eggen A.E. The Tromso Study: frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). J Clin Epidemiol. 46:1993;1297-1304.
17. Antonov K.I., Isacson D.G. Prescription and nonprescription analgesic use in Sweden. Ann Pharmacother. 32:1998;485-494.